dcc-3116
deciphera
['agent', 'dcc-3116', 'deciphera']
deciphera pharmaceuticals, inc. presents initial phase 1 single agent dose escalation data for first-in-class ulk inhibitor of autophagy, dcc-3116, at the european society for medical oncology (esmo) congress 2022 - 
MD MSC CPDS https://t.co/kePCRsvthW  https://t.co/t7oxnCDRg8  #cardiology  #AI #informatics #healthcare #innovation #entrepreneur RSS feeds